Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Useful Contacts |
  6. Site Map |
  7. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Contact us

Sanofi
Talavera Corporate Centre
Building D
12-24 Talavera Road
Macquarie Park, NSW 2113
+61 (0)2 8666 2000

Content :

Transparency

Payments made to Healthcare Professionals, Healthcare Organisations and Patient Associations

As a global healthcare leader, we recognise our responsibility to be transparent in our working relationships with healthcare professionals, patient associations and healthcare organisations.

Why is transparency important?

Collaboration between industry, healthcare professionals and healthcare organisations is a vital part of enabling the development and effective use of new medicines and in shaping the future of research. Bringing greater transparency to these already well-regulated and legitimate relationships aims to build greater understanding of the collaboration between industry, healthcare professionals and healthcare organisations. We are committed to greater transparency in our industry and will continue to strive for the highest possible standards.

Why are we working with healthcare professionals, healthcare organisations and patient associations?

The healthcare professionals, healthcare organisations and patient associations with whom we work provide us with valuable, independent and expert knowledge derived from their clinical and disease management experience. We are dedicated to delivering a high quality service to patients. Collaborating with experts contributes significantly to our efforts to improve the quality of patient care, with benefits for individuals and society at large.

What is Sanofi’s commitment regarding transparency?

We believe that transparency reflects on credibility and engenders confidence in our company. We are committed to complying with all applicable rules and regulations governing transparency.

Transfer of Value Reporting

As a member of Medicines Australia, Sanofi has prepared a report on all Transfers of Value (ToV) for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and Australia’s Privacy Legislation.

The ToV report will include payments of honoraria or consultancy for services provided, air travel, accommodation or registration fees paid on behalf of an Australian Healthcare Professional. This report includes the Healthcare Professional’s name, address, specialty, nature and dollar value of the ToV and will be available for a period of three years from the date of first publication.

For the period of 1 October 2015 – 30 September 2016, reporting only occurred with the consent of the HCP concerned. Where consent was not obtained the information was provided in aggregate without naming the HCP.

From 1 October 2016, reporting these payments will be mandatory.

Our most recent report is below

Previous reports are also available

The report is designed to be read on this website. It is also provided as a downloadable CSV file.

To comply with our privacy obligations, the report may be amended from time to time. The report here contains the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988.

Sponsorship of Third Party Organisations

A report of all payments made to Third Party Organisations for sponsorship of independent medical meetings or symposia, will be made available on the Medicines Australia website on 31 August, 2016 and will thereafter be provided six monthly to Medicines Australia. Publication of this report will be made available on the Medicines Australia website within two months of the date of providing this report to Medicines Australia.

Health Consumer Organisation Report

This report is made available to Medicines Australia by 30 April each year and Medicines Australia will make publically available, on its website, the completed Health Consumer Organisation Report within two months of the date of receipt from Sanofi.

Updated: August 29, 2017